CSIMarket


Amgen Inc   (AMGN)
Other Ticker:  
 


 

Amgen Inc

AMGN's Financial Statements and Analysis



Amgen Inc reported in III. Quarter net earnings per share of $3.98 an increase by 20.24 % year on year from $3.31 and an improvement of 62.45 % from $2.45 realized in II. Quarter (Jun 30 2022).


III. Quarter
Earnings Per Share Revenues
$ 3.98 $  0 Mill
$+0.67     +20.24 % Unch.    



Amgen Inc 's Revenue fell by 0 % in III. Quarter (Sep 30 2022) year on year, to $0 million and declined by sequentially.


Amgen Inc is Expected to report next financial results on February 15, 2023.

More on AMGN's Income Statement





       
  • United States 20.18% Y/Y,
• EPOGEN TM 88.8% Y/Y,
• Aranesp 4.01% Y/Y,
• Prolia 25.49% Y/Y,
• Nplate 15.13% Y/Y,
• Neulasta 94.72% Y/Y,
• XGEVA 18.87% Y/Y,
• ENBREL 30.27% Y/Y
   
     
       
  • International -6.43% Y/Y,
• NEUPOGEN -5.33% Y/Y,
• Vectibix -60.87% Y/Y
   
     


AMGN's Segments

Amgen Inc 's net income of $2,143.000 million in III. Quarter increased by 13.75 % from net earnings of $1,884.000 million achieved in III. Quarter a year ago.

Sequentially net earnings grew by 62.72 % from net income of $1,317.000 million realized in previous quarter.

More on AMGN's Growth

Inventories grew by 14.57 % to $4,757 million from III. Quarter a year ago, sequentially inventories rose by 4.46 %. AMGN's Cash flow In III. Quarter company's net cash flow was $4,299 million, capital expenditures grew by -33.88%, to $-160 millions compare to same quarter a year ago and rose by -34.96% from II. Quarter (Jun 30 2022).

More on AMGN's Cash flow Statement


Amgen Inc payed out dividend of $7.57 per share in last 52 weeks representing 60.71 % of net earning per share in trailing twelve-month period.

During the same period Amgen Inc earned $ 18.36 cash per share, on a free-cash flow basis 147.27 % of net earning per share.